Trial reportEpilepsia open2026
A multicenter, video-EEG-based validation of a multimodal wearable device for focal seizure detection in adults: The SeizeIT2 study.
Trial report in Epilepsia open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
Abstract
objectiveCurrently available wearable devices for detecting focal seizures primarily target major motor seizures or involve semi-invasive subscalp implants. There is a pressing need for accurate, non-invasive methods to detect diverse focal seizures for long-term, out-of-hospital monitoring.
methodsIn this multicenter study (SeizeIT2), people with refractory focal epilepsy undergoing long-term video-electroencephalography (EEG) monitoring were simultaneously recorded with the Sensor Dot, a multimodal wearable device using EEG and electrocardiography (ECG). Wearable recordings were first processed with an offline detection algorithm, after which the algorithm-labeled segments underwent blinded review by a human expert, and results were compared with ground truth video-EEG. Post-hoc analyses were performed to evaluate how specific seizure characteristics, defined by the gold-standard recordings, influenced detection sensitivity.
resultsWe recruited 192 adult participants, documenting a total of 616 focal seizures. The mean duration of Sensor Dot monitoring was 5 days. The seizure detection algorithm achieved an overall sensitivity of 0.73, precision of 0.004 and F1 score of 0.01. Following human review, a precision of 0.83 was achieved, albeit with a sensitivity of 0.31, resulting in an F1 score of 0.45. Seizure detection was influenced by the seizure type (focal impaired awareness seizure (FIAS) or focal-to-bilateral tonic-clonic seizures (FBTCS)) and the presence of a distinct ictal pattern on behind-the-ear EEG, constituting mostly temporal lobe seizures. In a post-hoc subgroup analysis of seizures with a clear ictal EEG pattern and ictal tachycardia (as determined by the ground truth), a sensitivity of 0.74 was observed, whereas a sensitivity of 0.60 was achieved when there was visible electrographic seizure activity without tachycardia. SIGNIFICANCE: The overall performance of the Sensor Dot in focal seizure detection was limited in an unselected group of focal seizure types. Our findings suggest that the proposed approach, combining algorithm-based detection with human review, provides detection performance comparable with diary self-reporting, in terms of sensitivity, but with higher precision (0.83 vs. 0.60). Our findings suggest that this multimodal approach may be particularly beneficial for the subset of patients whose seizures are characterized by distinct ictal EEG patterns and tachycardia-features frequently seen in temporal lobe epilepsy. However, the prospective utility of these markers for patient selection requires further validation. PLAIN LANGUAGE SUMMARY: Wearable devices may help improve seizure detection in people with epilepsy, but few non-invasive options exist for detecting focal seizures. We studied a behind-the-ear wearable device (Sensor Dot) using automated analysis combined with expert review. Overall, this approach resulted in detection of seizures with low sensitivity but high precision. Post-hoc subgroup analysis suggested that for seizures characterized by a distinct ictal EEG pattern and tachycardia-features often seen in temporal lobe epilepsy-this multimodal approach achieved a sensitivity of 0.74. Further prospective validation is required to confirm if this performance can be replicated through pre-monitoring patient selection.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.